Adherence to Rivaroxaban, Dabigatran, and Apixaban for Stroke Prevention in Incident, Treatment-Naïve Nonvalvular Atrial Fibrillation

BACKGROUND: Non-vitamin K antagonist oral anticoagulants (NOACs) are widely used for prevention of stroke secondary to nonvalvular atrial fibrillation (NVAF). Increased use of NOACs is partially a result of simplified regimens compared with warfarin, which has been associated with poor adherence and...

Descripción completa

Detalles Bibliográficos
Autores principales: Brown, Joshua D., Shewale, Anand R., Talbert, Jeffery C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5751430/
https://www.ncbi.nlm.nih.gov/pubmed/27783556
http://dx.doi.org/10.18553/jmcp.2016.22.11.1319

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5751430/
https://www.ncbi.nlm.nih.gov/pubmed/27783556
http://dx.doi.org/10.18553/jmcp.2016.22.11.1319

Ejemplares similares